HEMOCATH

​HemoCath Ltd. is an early-stage Canadian/US/Irish company that has developed and is now commercializing outside the United States the HemoCath Pulmonary Artery (PA) Catheter, indicated for the assessment of a patient's hemodynamic condition through direct simultaneous CVP and PAP monitoring... Hemocath Intelligent Heart Failure Monitoring Platform - Pulmonary artery pressure (PAP)-guided heart failure therapy, diagnostic and monitoring have shown to reduce hospital length of stay and rehospitalization

Also known as: HemoCath Ltd

Primary location: Lisle United States